Abstract:BACKGROUND: Traumatic spinal cord injuries (SCI) have devastating consequences for the physical, financial, and psychosocial well-being of patients and their caregivers. Expediently delivering interventions during the early postinjury period can have a tremendous impact on long-term functional recovery.PATHOPHYSIOLOGY: This is largely due to the unique pathophysiology of SCI where the initial traumatic insult (primary injury) is followed by a progressive secondary injury cascade characterized by ischemia, proapoptotic signaling, and peripheral inflammatory cell infiltration. Over the subsequent hours, release of proinflammatory cytokines and cytotoxic debris (DNA, ATP, reactive oxygen species) cyclically adds to the harsh postinjury microenvironment. As the lesions mature into the chronic phase, regeneration is severely impeded by the development of an astroglial-fibrous scar surrounding coalesced cystic cavities. Addressing these challenges forms the basis of current and upcoming treatments for SCI.MANAGEMENT: This paper discusses the evidence-based management of a patient with SCI while emphasizing the importance of early definitive care. Key neuroprotective therapies are summarized including surgical decompression, methylprednisolone, and blood pressure augmentation. We then review exciting neuroprotective interventions on the cusp of translation such as Riluzole, Minocycline, magnesium, therapeutic hypothermia, and CSF drainage. We also explore the most promising neuroregenerative strategies in trial today including Cethrin™, anti-NOGO antibody, cell-based approaches, and bioengineered biomaterials. Each section provides a working knowledge of the key preclinical and patient trials relevant to clinicians while highlighting the pathophysiologic rationale for the therapies.CONCLUSION: We conclude with our perspectives on the future of treatment and research in this rapidly evolving field.

The Current Update of Conventional and Innovative Treatment Strategies for Central Nervous System Injury

Comprehensive Therapeutics Targeting the Corticospinal Tract Following Spinal Cord Injury

A Brief Summary of Current Therapeutic Strategies for Spinal Cord Injury

Current Treatments after Spinal Cord Injury: Cell Engineering, Tissue Engineering, and Combined Therapies

Advancements in neuroregenerative and neuroprotective therapies for traumatic spinal cord injury

The Potential of Stem Cells in Treatment of Traumatic Brain Injury

Update on the treatment of spinal cord injury

Traumatic Spinal Cord Injury—Repair and Regeneration

New Insights into the Biological Roles of Immune Cells in Neural Stem Cells in Post-Traumatic Injury of the Central Nervous System

Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications

Advances in Novel Biomaterial-Based Strategies for Spinal Cord Injury Treatment

Stem Cell Therapies for Central Nervous System Trauma: The 4 Ws—What, When, Where, and Why

Spinal cord injury: molecular mechanisms and therapeutic interventions

Cellular Transplantation-Based Evolving Treatment Options in Spinal Cord Injury

Future Perspectives in Spinal Cord Repair: Brain as Saviour? TSCI with Concurrent TBI: Pathophysiological Interaction and Impact on MSC Treatment

Recent progress and challenges in the treatment of spinal cord injury

Neurotrauma—From Injury to Repair: Clinical Perspectives, Cellular Mechanisms and Promoting Regeneration of the Injured Brain and Spinal Cord

Natural recovery and regeneration of the central nervous system

Advances in Neural Stem Cell Therapy for Spinal Cord Injury: Safety, Efficacy, and Future Perspectives

Traumatic brain injury: Symptoms to systems in the 21st century